Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other 1

Conditions

Multiple Myeloma 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Lymphoma 19Leukemia, Myeloid, Acute 18Myelodysplastic Syndromes 17Lymphoma, Non-Hodgkin 14Neoplasms, Plasma Cell 12Leukemia 12Neuroblastoma 11Leukemia, Lymphocytic, Chronic, B-Cell 11Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 9Recurrence 7Melanoma 7Lymphoma, Mantle-Cell 7Hematologic Neoplasms 7Burkitt Lymphoma 7Sarcoma 6Ovarian Neoplasms 6Myeloproliferative Disorders 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Follicular 6Sarcoma, Ewing 5Neoplasm Metastasis 5Medulloblastoma 5Lymphoma, B-Cell, Marginal Zone 5Liver Neoplasms 5Wilms Tumor 4Rhabdomyosarcoma 4Retinoblastoma 4

Interventions

angiotensin I (1-7) 1Traumeel S 1Sodium Chloride 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Melphalan 1Fibroblast Growth Factor 7 1Drug Therapy 1Cisplatin 1CBLB502 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Mucositis × Melphalan × Clear all
NCT00482846 2014-04-15

Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma

Barbara Ann Karmanos Cancer Institute

Phase 1 Completed
38 enrolled
OtherPlasma cell

Multiple Myeloma, Mucositis, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡